A simple IV fluid choice could tame pancreatitis severity
NCT ID NCT05781243
First seen Aug 18, 2026 · Last updated Aug 18, 2026
Summary
This trial tests whether the type of IV fluid given to people with acute pancreatitis affects how severe the disease becomes. About 800 adults with acute pancreatitis will be randomly assigned to receive either lactated Ringer's solution or normal saline for at least 48 hours. The goal is to see if one fluid reduces the chance of developing moderately severe or severe pancreatitis, which involves complications or organ failure. The results could lead to a simple, inexpensive change in emergency care worldwide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lactated Ringer's solution compared to normal saline, given as intravenous fluid resuscitation for at least 48 hours
- What this could lead to
- If lactated Ringer's proves better, it could become the standard IV fluid for acute pancreatitis, reducing severe complications worldwide at low cost.
- What could go wrong
- Previous studies have shown conflicting results, and this trial is open-label, which may introduce bias. The benefit, if any, may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Balmis General University Hospital
Alicante, Alicante, 03010, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict acute pancreatitis outcomes?
- Ancient herbal combo could speed healing in pancreatitis
- Blood test could spot deadly pancreatic infection earlier
- Could a simple phosphate IV ease severe pancreatitis?
- Scientists launch study to decode why diabetes affects people differently
- Emergency surgery outcomes under the microscope: what happens to patients?